T2 Biosystems Overview
- Year Founded
-
2006
- Status
-
Public
- Employees
-
113
- Stock Symbol
-
TTOO
- Share Price
-
$0.12
- (As of Tuesday Closing)
T2 Biosystems General Information
Description
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.
Contact Information
Website
www.t2biosystems.comCorporate Office
- 101 Hartwell Avenue
- Lexington, MA 02421
- United States
Corporate Office
- 101 Hartwell Avenue
- Lexington, MA 02421
- United States
T2 Biosystems Stock Performance
As of 22-Apr-2025, T2 Biosystems’s stock price is $0.12. Its current market cap is $3.42M with 28M shares.
(As of Tuesday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.12 | $0.12 | $0.06 - $6.80 | $3.42M | 28M | 1.01M | -$0.03 |
T2 Biosystems Financials Summary
As of 30-Sep-2024, T2 Biosystems has a trailing 12-month revenue of $7.68M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 49,410 | 50,573 | 49,409 | 101,552 |
| Revenue | 7,677 | 7,193 | 22,305 | 28,058 |
| EBITDA | (39,507) | (43,875) | (54,872) | (39,219) |
| Net Income | (42,954) | (50,077) | (62,003) | (49,241) |
| Total Assets | 18,082 | 34,797 | 34,327 | 60,539 |
| Total Debt | 18,944 | 49,498 | 59,217 | 58,323 |
T2 Biosystems Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
T2 Biosystems Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
T2 Biosystems Comparisons
Industry
Financing
Details
T2 Biosystems Competitors (25)
One of T2 Biosystems’s 25 competitors is Hain Lifescience, a Corporate Backed or Acquired company based in Nehren, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hain Lifescience | Corporate Backed or Acquired | Nehren, Germany | ||||
| BioGenex Laboratories | Corporation | Fremont, CA | ||||
| BacterioScan | Formerly VC-backed | Saint Louis, MO | ||||
| Curetis | Private Equity-Backed | Holzgerlingen, Germany | ||||
| Akonni Biosystems | Venture Capital-Backed | Frederick, MD |
T2 Biosystems Patents
T2 Biosystems Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4426864-A1 | Methods and systems for amplification and detection in biological samples | Pending | 03-Nov-2021 | ||
| US-20220348986-A1 | Methods and compositions for comprehensive and high sensitivity detection of pathogens and drug resistance markers | Pending | 19-Jun-2019 | ||
| AU-2020296183-A1 | Methods and compositions for comprehensive and high sensitivity detection of pathogens and drug resistance markers | Pending | 19-Jun-2019 | ||
| EP-3987048-A4 | Methods and compositions for comprehensive and high sensitivity detection of pathogens and drug resistance markers | Pending | 19-Jun-2019 | ||
| EP-3987048-A1 | Methods and compositions for comprehensive and high sensitivity detection of pathogens and drug resistance markers | Pending | 19-Jun-2019 | C12Q1/689 |
T2 Biosystems Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
T2 Biosystems Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
T2 Biosystems ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
T2 Biosystems FAQs
-
When was T2 Biosystems founded?
T2 Biosystems was founded in 2006.
-
Where is T2 Biosystems headquartered?
T2 Biosystems is headquartered in Lexington, MA.
-
What is the size of T2 Biosystems?
T2 Biosystems has 113 total employees.
-
What industry is T2 Biosystems in?
T2 Biosystems’s primary industry is Diagnostic Equipment.
-
Is T2 Biosystems a private or public company?
T2 Biosystems is a Public company.
-
What is T2 Biosystems’s stock symbol?
The ticker symbol for T2 Biosystems is TTOO.
-
What is the current stock price of T2 Biosystems?
As of 22-Apr-2025 the stock price of T2 Biosystems is $0.12.
-
What is the current market cap of T2 Biosystems?
The current market capitalization of T2 Biosystems is $3.42M.
-
What is T2 Biosystems’s current revenue?
The trailing twelve month revenue for T2 Biosystems is $7.68M.
-
Who are T2 Biosystems’s competitors?
Hain Lifescience, BioGenex Laboratories, BacterioScan, Curetis, and Akonni Biosystems are some of the 25 competitors of T2 Biosystems.
-
What is T2 Biosystems’s annual earnings per share (EPS)?
T2 Biosystems’s EPS for 12 months was -$0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
